Recall Register

Food, drugs, devices › Cardinal Health Inc.

Drug recall: Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA

FDA enforcement event 89976 · Class I · initiated 5 Apr 2022 · status Completed

DrugVoluntary: Firm initiated3 product recordsDublin, OH

Cardinal Health Inc. (Dublin, OH) initiated this drug recall on 5 Apr 2022; FDA lists 3 product records under event 89976, classified Class I.

FDA defines Class I as a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. 18% of the 325 drug enforcement events initiated in 2022 carry the same class.

Status: Completed. Initiation: voluntary: firm initiated. Cardinal Health Inc. has 12 enforcement events on this register, with a median of 3 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Cardinal Health Inc., Dublin, OH.

Reason for recall

"TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather."

Distribution

"NM only"

Product records

Recall numberProductQuantityClassStatusReport date
D-0882-2022Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-591 boxClass ICompleted25 May 2022
D-0883-2022Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-801 boxClass IICompleted25 May 2022
D-0884-2022Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-801 boxClass IICompleted25 May 2022

Context

18%of 2022 drug events are Class I325 events that year
3product records in this eventfirm median: 3
12events on this register for the firm

Other enforcement events for Cardinal Health Inc.

InitiatedProduct (first record)TypeClassRecords
5 Aug 2025Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefDrugClass II1
30 Jul 2025Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 5DrugClass II3
9 Apr 2025Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx ODrugClass II1
31 Oct 2023LEADER brand Eye Irritation Relief (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline Hydrochloride 0.05%), 0.5 FLDrugClass I6
16 Mar 2021FREESTYLE LANCETS 28G 100CT Item Number:2975670DeviceClass II14
15 Mar 2021THERAPEUTIC M 130; NDC/UPC 740985223680; OTC; TABLETSDrugClass II198
9 Mar 2021Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: JanssDrugClass III1
20 Apr 2020B-Hydroxybutyrate LiquiColor, Item code CH2440058 - Product Usage: Product is used for the quantitative determination ofDeviceClass II3
26 Dec 2019Kangaroo Joey Safety Screw Spike with Flush Bag, Anti-free Flow,1000 mL, Product Code 765100DeviceClass II6
14 Nov 2019S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System. The SMART stent system includes a self-DeviceClass II3

All 12 events for Cardinal Health Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather."

What does Class I mean?

FDA classifies recalls by relative degree of health hazard. Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

Where was the product distributed?

FDA's distribution pattern field reads: "NM only"

Is the recall still ongoing?

FDA lists the status as Completed. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.